These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39086209)

  • 1. Using Latent Profile Analysis to Characterize Clinical Heterogeneity and Impulsivity in a Large Residential Addiction Treatment Program.
    Gendy MNS; Remers S; Samokhvalov AV; Sousa S; Rush B; Costello J; MacKillop J
    Subst Use Misuse; 2024; 59(12):1673-1682. PubMed ID: 39086209
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterizing Clinical Heterogeneity in a Large Inpatient Addiction Treatment Sample: Confirmatory Latent Profile Analysis and Differential Levels of Craving and Impulsivity.
    Minhas M; Cooper A; Sousa S; Costello MJ; MacKillop J
    Subst Abuse; 2022; 16():11782218221126977. PubMed ID: 36385746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of premature treatment termination in a large residential addiction medicine program.
    Syan SK; Minhas M; Oshri A; Costello J; Sousa S; Samokhvalov AV; Rush B; MacKillop J
    J Subst Abuse Treat; 2020 Oct; 117():108077. PubMed ID: 32811634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of co-occurring addictions, posttraumatic stress disorder, and major depressive disorder in detoxification treatment seekers: Implications for improving detoxification treatment outcomes.
    Anderson RE; Hruska B; Boros AP; Richardson CJ; Delahanty DL
    J Subst Abuse Treat; 2018 Mar; 86():45-51. PubMed ID: 29415850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Technology-Based Enhancements to Inpatient and Residential Treatment for Young Adult Women with Co-Occurring Substance Use.
    Sugarman DE; Meyer LE; Reilly ME; Rauch SL; Greenfield SF
    J Dual Diagn; 2021; 17(3):236-247. PubMed ID: 34261413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Profile Analysis of Heavy Episodic Drinking in Emerging Adults: A Reinforcer Pathology Approach.
    Minhas M; Oshri A; Amlung M; Dennhardt A; Ferro M; Halladay J; Munn C; Tucker J; Murphy J; MacKillop J
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2130-2140. PubMed ID: 32965723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring post-traumatic stress disorder and substance use disorders.
    López-Castro T; Hu MC; Papini S; Ruglass LM; Hien DA
    Drug Alcohol Rev; 2015 May; 34(3):242-51. PubMed ID: 25735200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.
    Roberts NP; Roberts PA; Jones N; Bisson JI
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010204. PubMed ID: 27040448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment receipt patterns among individuals with co-occurring posttraumatic stress disorder (PTSD) and substance use disorders.
    Simpson TL; Hawrilenko M; Goldberg S; Browne K; Lehavot K; Borowitz M
    J Consult Clin Psychol; 2020 Nov; 88(11):1039-1051. PubMed ID: 32790452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysubstance use in young people accessing residential and day-treatment services for substance use: substance use profiles, psychiatric comorbidity and treatment completion.
    Mefodeva V; Carlyle M; Walter Z; Chan G; Hides L
    Addiction; 2022 Dec; 117(12):3110-3120. PubMed ID: 35851706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs.
    Shover CL; Abraham A; D'Aunno T; Friedmann PD; Humphreys K
    J Subst Abuse Treat; 2019 Oct; 105():44-50. PubMed ID: 31443890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of substance use disorders: Effects on patients with higher or lower levels of PTSD symptoms.
    Wieferink CEM; de Haan HA; Dijkstra BAG; Fledderus M; Kok T
    Addict Behav; 2017 Nov; 74():122-126. PubMed ID: 28622616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression, anxiety, and stress in young adult gamers and their relationship with addictive behaviors: A latent profile analysis.
    Aonso-Diego G; González-Roz A; Weidberg S; Secades-Villa R
    J Affect Disord; 2024 Dec; 366():254-261. PubMed ID: 39218313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder.
    Fortuna LR; Porche MV; Padilla A
    Psychol Psychother; 2018 Mar; 91(1):42-62. PubMed ID: 28815876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study.
    Ellis JD; Rabinowitz JA; Ware OD; Wells J; Dunn KE; Huhn AS
    J Subst Use Addict Treat; 2023 Mar; 146():208932. PubMed ID: 36880895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-morbid post-traumatic stress disorder in a substance misusing clinical population.
    Reynolds M; Mezey G; Chapman M; Wheeler M; Drummond C; Baldacchino A
    Drug Alcohol Depend; 2005 Mar; 77(3):251-8. PubMed ID: 15734225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative and unique contributions of emotion dysregulation and impulsivity to posttraumatic stress disorder among substance dependent inpatients.
    Weiss NH; Tull MT; Anestis MD; Gratz KL
    Drug Alcohol Depend; 2013 Feb; 128(1-2):45-51. PubMed ID: 22917752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Individualized Addictions Consultation Team Residential Program: A Creative Solution for Integrating Care for Veterans With Substance Use Disorders Too Complex for Other Residential Treatment Programs.
    Keating S; Larsen SE; Collingwood J; Smith HM
    J Dual Diagn; 2021; 17(2):172-179. PubMed ID: 33583351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.
    Roos CR; Bowen S; Witkiewitz K
    J Consult Clin Psychol; 2017 Nov; 85(11):1041-1051. PubMed ID: 29083220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dissociative subtype of PTSD in women with substance use disorders: Exploring symptom and exposure profiles.
    Gidzgier P; Grundmann J; Lotzin A; Hiller P; Schneider B; Driessen M; Schaefer M; Scherbaum N; Hillemacher T; Schäfer I
    J Subst Abuse Treat; 2019 Apr; 99():73-79. PubMed ID: 30797397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.